Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
暂无分享,去创建一个
Miguel O. Jara | R. Williams | Rishi Thakkar | J. J. Koleng | Zachary N. Warnken | S. Sahakijpijarn | D. Christensen | Vineet R. Kulkarni | Sawittree Sahakijpijarn
[1] Linc Chen,et al. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions. , 2022, Molecular pharmaceutics.
[2] Geoff G. Z. Zhang,et al. Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets , 2022, Pharmaceutical Research.
[3] Essentials of Industrial Pharmacy , 2022, AAPS Advances in the Pharmaceutical Sciences Series.
[4] D. Needham. The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections , 2021, Pharmaceutical Research.
[5] M. Sahini,et al. Cation–π interactions drive hydrophobic self-assembly and aggregation of niclosamide in water , 2021, RSC advances.
[6] A. Estevez,et al. Impact of Surfactant Selection and Incorporation on in situ Nanoparticle Formation from Amorphous Solid Dispersions. , 2021, International journal of pharmaceutics.
[7] Hyun Jin Park,et al. Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs , 2021, Journal of Chromatography B.
[8] Ruochen Yang,et al. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection. , 2021, Molecular pharmaceutics.
[9] J. Choy,et al. Niclosamide–Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment , 2021, Polymers.
[10] M. Sudheesh,et al. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions , 2021, Drug development and industrial pharmacy.
[11] Miguel O. Jara,et al. Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study , 2021, Pharmaceutics.
[12] Christel A. S. Bergström,et al. Molecular dynamics simulations reveal membrane interactions for poorly water-soluble drugs: impact of bile solubilization and drug aggregation. , 2020, Journal of pharmaceutical sciences.
[13] Ravi P. Shah,et al. Cross linking of poly (vinyl alcohol) films under acidic and thermal stress. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] Gerard R. Klinzing,et al. The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone , 2020, Pharmaceutical Research.
[15] Jia Zhou,et al. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential , 2020, ACS infectious diseases.
[16] P. Langguth,et al. Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times , 2020, Pharmaceutics.
[17] Cordula Stillhart,et al. Formulating amorphous solid dispersions: Impact of inorganic salts on drug release from tablets containing Itraconazole-HPMC extrudate. , 2019, Molecular pharmaceutics.
[18] G. Simpson,et al. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media , 2019, Pharmaceutical Research.
[19] R. Löbenberg,et al. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] L. Benning,et al. A template-free and low temperature method for the synthesis of mesoporous magnesium phosphate with uniform pore structure and high surface area. , 2019, Nanoscale.
[21] K. Kawakami,et al. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions. , 2019, Molecular pharmaceutics.
[22] L. S. Taylor,et al. Congruent release of drug and polymer: A “sweet spot” in the dissolution of amorphous solid dispersions , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[23] Anil Kane,et al. Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate‐based release retarding materials: Effect of dosage form design , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] M. Mohutsky,et al. Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water‐soluble drugs , 2018, International journal of pharmaceutics.
[25] R. Williams,et al. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update. , 2018, International journal of pharmaceutics.
[26] R. Premont,et al. Niclosamide: Beyond an antihelminthic drug , 2017, Cellular Signalling.
[27] Christel A. S. Bergström,et al. Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid , 2017, The journal of physical chemistry. B.
[28] Jeffrey M. Ting,et al. Direct Observation of Nanostructures during Aqueous Dissolution of Polymer/Drug Particles , 2017 .
[29] B. Aungst,et al. Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options. , 2017, Journal of pharmaceutical sciences.
[30] L. A.,et al. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products. , 2017, Journal of pharmaceutical and biomedical analysis.
[31] P. Leeson,et al. Quality guidelines for oral drug candidates: dose, solubility and lipophilicity. , 2016, Drug discovery today.
[32] W. Xu,et al. Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion. , 2016, Molecular pharmaceutics.
[33] Mayur S. Dudhedia,et al. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach , 2016, AAPS PharmSciTech.
[34] Alan B. Watts,et al. Formulating Poorly Water Soluble Drugs , 2016, AAPS Advances in the Pharmaceutical Sciences Series.
[35] X. Ren,et al. Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure. , 2015, Bioorganic & medicinal chemistry.
[36] N. Hellmann,et al. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development. , 2015, Journal of pharmaceutical sciences.
[37] Bernd Meibohm,et al. Applied Pharmacometrics (AAPS Advances in the Pharmaceutical Sciences Series) , 2015, CPT: Pharmacometrics & Systems Pharmacology.
[38] G. Marosi,et al. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. , 2015, International journal of pharmaceutics.
[39] W. Massad,et al. On the photooxidation of the multifunctional drug niclosamide. A kinetic study in the presence of vitamin B2 and visible light , 2015, Redox report : communications in free radical research.
[40] N. Vadia,et al. Development and validation of stability indicating RP-HPLC and HPTLC for determination of Niclosamide in bulk and in synthetic mixture , 2015 .
[41] S. Shantier,et al. STABILITY STUDIES ON NICLOSAMIDE USING DERIVATIVE SPECTROSCOPIC AND CHROMATOGRAPHIC METHODS , 2015 .
[42] Khairi Mustafa Salem Fahelelbom,et al. Performances of New Generation of Delayed Release Capsules , 2014 .
[43] H. Zaazaa,et al. Kinetic study and mechanism of Niclosamide degradation. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[44] Waseem Kaialy,et al. Computational predictions of glass-forming ability and crystallization tendency of drug molecules. , 2014, Molecular pharmaceutics.
[45] S. Onoue,et al. Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility , 2014, Expert opinion on drug delivery.
[46] Dave A. Miller,et al. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] G. Mooter,et al. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. , 2012, Drug discovery today. Technologies.
[48] A. Bansal,et al. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion. , 2011, Journal of pharmaceutical sciences.
[49] M. Brewster,et al. Pharmaceutical applications of cyclodextrins: basic science and product development , 2010, The Journal of pharmacy and pharmacology.
[50] Feng Qian,et al. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.
[51] Alan M. Smith,et al. Polymer film formulations for the preparation of enteric pharmaceutical capsules , 2010, The Journal of pharmacy and pharmacology.
[52] A. Rajabi-Siahboomi,et al. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies , 2010, Drug development and industrial pharmacy.
[53] A. Rajabi-Siahboomi,et al. Evaluation of recent advances in continuous film coating processes , 2010, Drug development and industrial pharmacy.
[54] Martin Kuentz,et al. Study of a Standardized Taurocholate- Lecithin Powder for Preparing the Biorelevant Media FeSSIF and FaSSIF , 2010 .
[55] S. Badawy,et al. Microenvironmental pH modulation in solid dosage forms. , 2007, Journal of pharmaceutical sciences.
[56] M. D. de Villiers,et al. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. , 2005, International journal of pharmaceutics.
[57] A. P. Lötter,et al. Comparison of the Physical and Chemical Stability of Niclosamide Crystal Forms in Aqueous Versus Nonaqueous Suspensions , 2004, Drug development and industrial pharmacy.
[58] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[59] A. Gürsoy,et al. Preparation and Properties of Tablets Prepared from Furosemide-PVP Solid Dispersion Systems , 1988 .